The BARCODE1 Pilot: a feasibility study of using germline SNPs to target prostate cancer screening. Benafif S, Ni Raghallaigh H, McGrowder E, Saunders EJ, et al. BJU Int 2021 Jul 2. doi: 10.1111/bju.15535.

Read + Share

Amedeo Smart

Independent Medical Education

Benafif S, Ni Raghallaigh H, McGrowder E, Saunders EJ, et al. The BARCODE1 Pilot: a feasibility study of using germline SNPs to target prostate cancer screening. BJU Int 2021 Jul 2. doi: 10.1111/bju.15535.
PMID: 34214236